Moors & Cabot’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,650
| Closed | -$187K | – | 838 |
|
|
2023
Q3 | $187K | Buy |
16,650
+3,900
| +31% | +$43.8K | 0.01% | 759 |
|
|
2023
Q2 | $128K | Sell |
12,750
-9,233
| -42% | -$92.9K | 0.01% | 785 |
|
|
2023
Q1 | $207K | Sell |
21,983
-1,292
| -6% | -$12.1K | 0.01% | 746 |
|
|
2022
Q4 | $284K | Sell |
23,275
-5,950
| -20% | -$72.7K | 0.02% | 606 |
|
|
2022
Q3 | $363K | Sell |
29,225
-1,542
| -5% | -$19.2K | 0.03% | 501 |
|
|
2022
Q2 | $604K | Buy |
30,767
+125
| +0.4% | +$2.45K | 0.04% | 368 |
|
|
2022
Q1 | $799K | Sell |
30,642
-225
| -0.7% | -$5.87K | 0.05% | 346 |
|
|
2021
Q4 | $876K | Buy |
30,867
+275
| +0.9% | +$7.8K | 0.05% | 315 |
|
|
2021
Q3 | $977K | Buy |
30,592
+4,500
| +17% | +$144K | 0.06% | 287 |
|
|
2021
Q2 | $905K | Buy |
26,092
+3,900
| +18% | +$135K | 0.06% | 278 |
|
|
2021
Q1 | $656K | Buy |
22,192
+745
| +3% | +$22K | 0.05% | 333 |
|
|
2020
Q4 | $658K | Buy |
21,447
+1,830
| +9% | +$56.1K | 0.06% | 295 |
|
|
2020
Q3 | $548K | Buy |
19,617
+589
| +3% | +$16.5K | 0.05% | 314 |
|
|
2020
Q2 | $403K | Buy |
19,028
+6,378
| +50% | +$135K | 0.04% | 366 |
|
|
2020
Q1 | $281K | Sell |
12,650
-5,850
| -32% | -$130K | 0.04% | 390 |
|
|
2019
Q4 | $544K | Buy |
18,500
+6,450
| +54% | +$190K | 0.05% | 323 |
|
|
2019
Q3 | $323K | Buy |
+12,050
| New | +$323K | 0.04% | 425 |
|